Navigating the Journey: Symptoms and Progression
At a Glance
Fukuyama congenital muscular dystrophy causes early motor delays and progressive weakness and can affect seizures, breathing, heart health, swallowing, and the spine. Regular monitoring by a coordinated care team helps families plan for changing support needs.
Fukuyama Congenital Muscular Dystrophy (FCMD) is a multisystem condition. Because the genetic mutation affects the cells in the muscles, brain, and eyes, the disease follows a progressive path that involves multiple aspects of your child’s health. While every child’s journey is unique, understanding the typical milestones and potential complications can help you prepare for the care they will need [1][2].
Early Childhood: Motor Milestones
The first signs of FCMD usually appear in early infancy. You may notice your baby feels “floppy” (hypotonia) or has a weak cry and difficulty feeding [1].
- Motor Delays: Most children with FCMD experience significant delays in reaching physical milestones like holding their head up, rolling over, or sitting [2].
- Walking: The vast majority of children with classic FCMD do not achieve the ability to walk independently [3]. Some children may learn to slide on their bottoms (shuffling) or sit without support, but this may not happen until later in childhood [4].
- Progressive Weakness: While children do gain some new skills early on, the underlying muscle weakness is progressive [2]. This means that as children get older and heavier, their muscles may struggle to keep up with the demands of their growing bodies [3].
Neurological Symptoms: Cognition and Seizures
Because FCMD affects brain development, it involves symptoms that go beyond the muscles.
- Developmental Profile: Children with FCMD often have a broad and variable developmental profile. Formal IQ testing may not be valid or meaningful because severe motor, speech, and vision impairments can mask a child’s true cognitive abilities. It is vital to focus on functional assessments, hearing evaluations, and the use of augmentative and alternative communication (AAC) devices to help your child express themselves [1].
- Seizures and Epilepsy: Seizures are common, affecting many children [5][1].
- Timing: Seizures can begin in early childhood, often triggered by fevers. Because of the underlying cortical malformation, fever-triggered events may represent true epilepsy. Epilepsy can also emerge for the first time during adolescence [6].
- The “Weakness Mask”: In older children, seizures can be harder to spot because profound muscle weakness may prevent the typical “shaking” movements of a convulsion. Instead, seizures might look like staring spells, behavioral pauses, or temporary “blankness” [6]. However, staring or blankness is nonspecific and can also reflect sleepiness, pain, medication effects, or poor nighttime breathing (hypoventilation).
The “Systemic” Shift: Respiratory and Cardiac Health
As children grow, the focus of care often shifts from motor milestones to managing the internal systems of the body. While timing is individualized, cohort studies have observed general trends:
- Respiratory Decline: The muscles used for breathing can weaken over time. Many children eventually require breathing support—usually a non-invasive mask worn at night (NIV) to help with oxygen and carbon dioxide exchange. In one study cohort, the median age for starting NIV was about 12 years, though this varies widely [7]. Some children may need this support earlier depending on their specific phenotype.
- Heart Health: A portion of patients develop heart complications, such as cardiomyopathy (weakening of the heart muscle) or irregular heartbeats [5][8]. Heart issues can sometimes progress rapidly, making regular surveillance critical regardless of physical muscle strength [9][10].
Orthopedic and Feeding Challenges
Growing bodies with weak muscles often face physical changes that require intervention:
- Scoliosis: A curvature of the spine is very common in non-ambulatory children. Some children develop severe scoliosis that can make sitting painful and interfere with breathing [11]. Surgery to stabilize the spine is sometimes considered, but decisions depend on curve progression, sitting balance, respiratory reserve, and family goals.
- Swallowing (Dysphagia): Weakness in the throat muscles can make swallowing difficult [5]. This increases the risk of “aspiration” (food or liquid entering the lungs), which can cause pneumonia. A feeding tube (gastrostomy) is a complex decision made with a multidisciplinary team to ensure the child stays hydrated and nourished safely [12].
Common questions in this guide
How does FCMD affect motor development in early childhood?
How can seizures look in a child with FCMD?
When might a child with FCMD need breathing support?
Why does FCMD require regular heart monitoring?
What communication tools can help a child with FCMD express their needs?
How can scoliosis affect a child with FCMD?
How can swallowing problems affect a child with FCMD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my child's current muscle strength, what is the most realistic motor milestone we should work toward (sitting, rolling, or assisted standing)?
- 2.When should my child have their first baseline EEG, and what subtle signs of seizures (like staring spells or pauses) should I be looking for?
- 3.What alternative communication (AAC) tools might be appropriate to help my child express their needs?
- 4.How will we monitor for silent aspiration if my child's swallowing difficulties are not obvious during meals?
- 5.Is my child's current scoliosis or hip alignment likely to interfere with their ability to sit comfortably as they get older?
- 6.What are the earliest signs of respiratory decline we should watch for, beyond obvious breathing difficulty?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
[Central Nervous Involvement in Patients with Fukuyama Congenital Muscular Dystrophy].
Ishigaki K
Brain and nerve = Shinkei kenkyu no shinpo 2016; (68(2)):119-27 doi:10.11477/mf.1416200361.
PMID: 26873231 - 2
Acute rhabdomyolysis following viral infection with coxsackie A4 in a 50-day-old infant with Fukuyama congenital muscular dystrophy.
Yamaguchi H, Taniguchi-Ikeda M, Nagase H, et al.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2020; (26(5)):516-519 doi:10.1016/j.jiac.2019.12.015.
PMID: 31983616 - 3
The gross motor function measure is valid for Fukuyama congenital muscular dystrophy.
Sato T, Adachi M, Nakamura K, et al.
Neuromuscular disorders : NMD 2017; (27(1)):45-49 doi:10.1016/j.nmd.2016.09.014.
PMID: 27818010 - 4
Spinal fusion in a patient with Fukuyama congenital muscular dystrophy.
Hino K, Fukuda M, Morino T, et al.
Brain & development 2017; (39(7)):613-616 doi:10.1016/j.braindev.2017.02.003.
PMID: 28318781 - 5
National registry of patients with Fukuyama congenital muscular dystrophy in Japan.
Ishigaki K, Ihara C, Nakamura H, et al.
Neuromuscular disorders : NMD 2018; (28(10)):885-893 doi:10.1016/j.nmd.2018.08.001.
PMID: 30220444 - 6
Epilepsy in patients with advanced Fukuyama congenital muscular dystrophy.
Kuwayama R, Suzuki Y, Nishikawa M, et al.
Brain & development 2021; (43(1)):106-110 doi:10.1016/j.braindev.2020.06.017.
PMID: 32723526 - 7
Respiratory management of patients with Fukuyama congenital muscular dystrophy.
Sato T, Murakami T, Ishiguro K, et al.
Brain & development 2016; (38(3)):324-30.
PMID: 26363734 - 8
Holter electrocardiography findings in Fukuyama congenital muscular dystrophy.
Sugiyama R, Takeshita E, Shimizu-Motohashi Y, Komaki H
Neuromuscular disorders : NMD 2025; (46()):105273 doi:10.1016/j.nmd.2024.105273.
PMID: 39798169 - 9
Rapidly progressive heart failure requiring transplantation in muscular dystrophy: a need for frequent screening.
Pick JM, Ellis ZD, Alejos JC, Chang AC
Cardiology in the young 2017; (27(9)):1836-1840 doi:10.1017/S1047951117001251.
PMID: 28689515 - 10
Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
Yamamoto T, Taniguchi-Ikeda M, Awano H, et al.
Brain & development 2017; (39(10)):861-868 doi:10.1016/j.braindev.2017.05.008.
PMID: 28578814 - 11
Spinal correction in patients with Fukuyama congenital muscular dystrophy.
Saito W, Namba T, Inoue G, et al.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2017; (22(4)):658-664 doi:10.1016/j.jos.2017.02.005.
PMID: 28325699 - 12
A case of Fukuyama-type congenital muscular dystrophy with acute carnitine deficiency triggered by fever, vomiting, and gastrointestinal bleeding.
Uchiyama SI, Korematsu S, Wasada R, et al.
Nutrition (Burbank, Los Angeles County, Calif.) 2023; (110()):112011 doi:10.1016/j.nut.2023.112011.
PMID: 36965241
This page is for informational purposes only and does not constitute medical advice. It describes common FCMD symptoms and progression; discuss your child’s breathing, seizures, swallowing, heart health, and development with their care team.
Get notified when new evidence is published on Congenital muscular dystrophy, Fukuyama type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.